Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$1.4 - $1.95 $57 - $79
41 New
41 $0
Q2 2022

Aug 15, 2022

SELL
$2.84 - $8.57 $470,684 - $1.42 Million
-165,734 Reduced 38.35%
266,400 $818,000
Q1 2022

May 16, 2022

BUY
$5.64 - $15.64 $1.66 Million - $4.61 Million
294,900 Added 214.89%
432,134 $3.12 Million
Q4 2021

Feb 14, 2022

BUY
$9.8 - $17.02 $1.34 Million - $2.34 Million
137,234 New
137,234 $2.25 Million

Others Institutions Holding PRDS

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.